<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1146</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>7518164</PubmedId>
            <Abstract>Two neutralization-resistant variants of dengue virus type 2 were selected using the neutralizing monoclonal antibody G8D11. Virus N-GV4 was derived from the New Guinea C strain and virus P-GV3 from the PUO-218 strain. Both variants had an identical change at nucleotide 919 in the E gene, causing a substitution of glutamic acid for lysine at residue 307 in the E glycoprotein. The substitution abolished the ability of antibody G8D11 to bind to the E glycoprotein in radioimmunoprecipitation experiments. The epitope was sensitive to treatment with SDS and was dependent on the formation of a disulfide bridge. This dependency was determined by mutagenesis of Cys residues 11 and 12 in the E glycoprotein.</Abstract>
            <ArticleYear>1994</ArticleYear>
            <ArticlePages>885-90</ArticlePages>
            <ArticleTitle>Localization of a neutralizing epitope on the envelope protein of dengue virus type 2.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Lin</LastName>
                    <ForeName>B</ForeName>
                </Author>
                <Author>
                    <LastName>Parrish</LastName>
                    <ForeName>C R</ForeName>
                </Author>
                <Author>
                    <LastName>Murray</LastName>
                    <ForeName>J M</ForeName>
                </Author>
                <Author>
                    <LastName>Wright</LastName>
                    <ForeName>P J</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Microbiology, Monash University, Clayton, Victoria, Australia.</Affiliations>
            <ArticleChemicalList>Antibodies, Monoclonal;Antibodies, Viral;DNA Primers;E-glycoprotein, Dengue virus type 2;Epitopes;Viral Envelope Proteins</ArticleChemicalList>
            <ArticleMeshHeadingsList>Antibodies, Monoclonal(immunology); Antibodies, Viral(immunology); Base Sequence; DNA Primers(chemistry); Dengue Virus(immunology); Epitopes; Molecular Sequence Data; Mutagenesis, Site-Directed; Neutralization Tests; Protein Denaturation; Structure-Activity Relationship; Viral Envelope Proteins(immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>202</Volume>
                <Issue>2</Issue>
                <Title>Virology</Title>
                <Issn>0042-6822</Issn>
                <MedlineTa>Virology</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeStructure>
                    <DiscontinuousRegionOnAccessionSequenceMolecule>
                        <ChemicalType>Discontinuous protein residues</ChemicalType>
                        <DiscontinuousResidues>K307</DiscontinuousResidues>
                        <SourceMolecule>
                            <GenBankId>AAT90433.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11060</SourceOrganismId>
                    </DiscontinuousRegionOnAccessionSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Abstract</LocationOfData>
                <EpitopeId>77075</EpitopeId>
                <ReferenceRegion>K307</ReferenceRegion>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Partial Epitope</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <BCellId>15973</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11060</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Dengue virus type 2</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The virus strain was grown in C6/36 cells. Mice were boosted 4 days prior to the fusion. Positive clones were selected by indirect fluorescent antibody.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>39</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>mAb G8D11 immunoprecipitated E glycoprotein of only parental viruses and failed to precipitate more than trace amounts of E glycoprotein from viral mutants (N-GV4 and P-GV3). The viral mutants had a substitution of lysine at residue 307 for glutamic acid. This study shows that lysine at position 307 of E glycoprotein is a key residue which affects the binding to viral mutants. The reactivity of the epitope was dependent on the disulphide bridge between Cys-11 and Cys-12.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>G8D11</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2a</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Dengue virus type 2</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>11060</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

